TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB
Application
US20260097048A1
Kind: A1
Apr 09, 2026
Inventors
Thomas Ronald A. QUINTEN, Urbain Alfons C. DELAET, Philip Erna H. HEYNS, Tatiana MARCOZZI, Johny BERTELS, Katrien LUYTEN, Kaustubh Ramesh TAMBWEKAR, Angela LOPEZ-GITLITZ, Paul J. A. HARTMAN KOK
Abstract
The present disclosure relates to a combination of abiraterone acetate and niraparib, free-dose and fixed-dose combinations of abiraterone acetate and niraparib, and methods of treatment of prostate cancer with said combinations.
CPC Classifications
A61K 31/58
A61K 9/1617
A61K 9/1635
A61K 9/1694
A61K 9/2009
A61K 9/2013
A61K 9/2018
A61K 9/2027
A61K 9/2054
A61K 9/28
A61K 31/454
A61K 31/573
A61K 38/25
A61P 13/08
A61P 15/00
A61P 35/00
A61P 35/04
Filing Date
2025-12-11
Application No.
19415909